Cargando…
Hyperlipidemia and mortality in patients on peritoneal dialysis
BACKGROUND: New lipid-lowering therapy at the start of dialysis and measurement of lipid parameters over the follow-up period is not recommended in dialysis patients, which seems unappropriated in clinical practice. We aimed to examine the effect of hyperlipidemia on mortality in patients undergoing...
Autores principales: | Feng, Xiaoran, Zhan, Xiaojiang, Wen, Yueqiang, Peng, FenFen, Wang, Xiaoyang, Wang, Niansong, Wu, Xianfeng, Wu, Junnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590170/ https://www.ncbi.nlm.nih.gov/pubmed/36280801 http://dx.doi.org/10.1186/s12882-022-02970-w |
Ejemplares similares
-
Monocyte/Lymphocyte Ratio and Cardiovascular Disease Mortality in Peritoneal Dialysis Patients
por: Wen, Yueqiang, et al.
Publicado: (2020) -
Creatine Kinase and Mortality in Peritoneal Dialysis
por: Wu, Xianfeng, et al.
Publicado: (2022) -
Low-Density Lipoprotein Cholesterol and Mortality in Peritoneal Dialysis
por: Wu, Xianfeng, et al.
Publicado: (2022) -
Hyperlipidemia and mortality associated with diabetes mellitus co-existence in Chinese peritoneal dialysis patients
por: Wei, Xin, et al.
Publicado: (2020) -
Coexistence of diabetes mellitus and pre-existing cardiovascular disease and mortality in Chinese patients on peritoneal dialysis
por: Lei, Guangtao, et al.
Publicado: (2022)